Hot Features
Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetu... Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.32 | 17.9775280899 | 1.78 | 2.12 | 1.7701 | 37528 | 1.99308097 | CS |
| 4 | -0.03 | -1.40845070423 | 2.13 | 2.2399 | 1.725 | 45813 | 1.9031411 | CS |
| 12 | -0.03 | -1.40845070423 | 2.13 | 2.3699 | 1.56 | 51696 | 1.95658209 | CS |
| 26 | -0.99 | -32.0388349515 | 3.09 | 3.85 | 1.56 | 56807 | 2.22642752 | CS |
| 52 | -0.39 | -15.6626506024 | 2.49 | 3.95 | 1.56 | 66373 | 2.64888399 | CS |
| 156 | -1.32 | -38.5964912281 | 3.42 | 12.355 | 1.37 | 246934 | 5.30346915 | CS |
| 260 | -12.91 | -86.0093271153 | 15.01 | 15.5 | 1.1 | 239951 | 4.52506576 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.